Alan F. Denenberg

Davis Polk advised the joint book-running managers in connection with a $460 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…

Davis Polk advised  the representatives of the several underwriters in connection with the $150 million initial public offering of 10,000,000 shares of common stock of Aligos…

Davis Polk advised the representatives of the several underwriters in connection with an initial public offering of 9,029,629 shares of common stock of Eargo, Inc. at $18.00 per share …

Davis Polk advised the representatives of the several underwriters in connection with the $50 million initial public offering of common stock by Aziyo Biologics, Inc. The common stock…

Davis Polk advised the joint book-running managers in connection with a $216.2 million public offering of 5,750,000 shares of common stock by NanoString Technologies, Inc., which…

Davis Polk advised Equinix, Inc. on an SEC-registered offering of $1.85 billion aggregate principal amount of senior notes. The offering consisted of $700 million aggregate principal amount…

  Davis Polk advised the representative of the initial purchasers on a Rule 144A/Regulation S debt offering by Carvana Co. of $500 million aggregate principal amount of its 5.625%…

The shares are listed on the New York Stock Exchange

Davis Polk advised the representatives of the several underwriters in connection with the $1.3 billion initial public offering of 39,807,691 shares of Class A common stock of GoodRx…

Davis Polk is advising CrowdStrike Holdings, Inc. in connection with its acquisition of Preempt Security, Inc., a leading provider of Zero Trust and conditional access technology for real…